Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-26-026476
Filing Date
2026-06-01
Accepted
2026-05-29 19:47:36
Documents
15
Effectiveness Date
2026-06-01

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 96048
2 EX-5.1 ex5-1.htm EX-5.1 23623
3 EX-23.1 ex23-1.htm EX-23.1 3724
4 EX-23.2 ex23-2.htm EX-23.2 3761
5 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 15994
6 GRAPHIC ex5-1_001.jpg GRAPHIC 3019
  Complete submission text file 0001493152-26-026476.txt   267058

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 4712
Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 (617) 444-8400
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-296379 | Film No.: 261046719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)